Insider Trading Activity - Vivo Capital Surplus Fund VIII L.P.

Real time insider trading transaction history:

Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Trading Transactions for Vivo Capital Surplus Fund VIII L.P.

Common stock purchase or sale:

Transaction Date	Reported DateTime	Company	Symbol	Insider Relationship	Shares Traded	Average Price	Total Amount	Shares Owned	Filing
2024-04-01 Sale	2024-04-03 8:47 pm	Terns Pharmaceuticals Inc.	TERN	Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner	420,663	$6.6487	$2,796,859	268,573 (Indirect)	View
2023-12-15 Sale	2023-12-19 6:00 pm	IMPEL PHARMACEUTICALS INC	IMPL	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner	575,000	$0.12892	$74,131	280,294 (Indirect)	View
2023-11-21 Sale	2023-11-22 6:51 pm	Bolt Biotherapeutics Inc.	BOLT	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Panda LLC Vivo Panda Fund L.P. 10% Owner	3,400	$0.9	$3,060	1,559,948 (Indirect)	View
2023-11-16 Sale	2023-11-20 9:09 pm	Bolt Biotherapeutics Inc.	BOLT	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Panda LLC Vivo Panda Fund L.P. 10% Owner	77,843	$0.92875	$72,297	1,561,405 (Indirect)	View
2022-12-23 Purchase	2022-12-23 5:48 pm	Terns Pharmaceuticals Inc.	TERN	Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner	758,620	$7.25	$5,499,995	6,657,992 (Indirect)	View
2022-09-07 Purchase	2022-09-08 8:00 pm	Terns Pharmaceuticals Inc.	TERN	Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner	600,000	$3.6	$2,160,000	5,899,372 (Indirect)	View
2022-08-12 Purchase	2022-08-16 8:44 pm	Terns Pharmaceuticals Inc.	TERN	Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner	2,624,239	$2.6599	$6,980,244	6,799,372 (Indirect)	View
2021-04-27 Purchase	2021-04-29 9:10 pm	IMPEL NEUROPHARMA INC	IMPL	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner	575,000	$15	$8,625,000	349,674 (Indirect)	View
2021-02-09 Purchase	2021-02-09 3:37 pm	Bolt Biotherapeutics Inc.	BOLT	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner	350,000	$20	$7,000,000	150,000 (Indirect)	View
2021-02-09 Sale	2021-02-09 3:37 pm	Bolt Biotherapeutics Inc.	BOLT	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner	226	$20	$4,520	150,000 (Indirect)	View
2021-02-09 Purchase	2021-02-09 3:08 pm	Terns Pharmaceuticals Inc.	TERN	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner	475,000	$17	$8,075,000	357,353 (Indirect)	View
2020-10-20 Purchase	2020-10-20 4:59 pm	Aligos Therapeutics Inc.	ALGS	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner	550,000	$15	$8,250,000	430,372 (Indirect)	View
2020-04-15 Sale	2020-04-17 6:38 pm	Crinetics Pharmaceuticals Inc.	CRNX	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner	330,598	$15.45	$5,106,752	298,625 (Indirect)	View
2020-04-03 Sale	2020-04-07 7:27 pm	Crinetics Pharmaceuticals Inc.	CRNX	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner	306,115	$13.81	$4,226,833	338,738 (Indirect)	View
2020-03-09 Sale	2020-03-11 5:12 pm	Crinetics Pharmaceuticals Inc.	CRNX	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner	528	$19.5	$10,296	168,165 (Indirect)	View
2020-02-07 Sale	2020-02-11 8:00 pm	Crinetics Pharmaceuticals Inc.	CRNX	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner	13,460	$21.66	$291,587	168,298 (Indirect)	View
2020-02-04 Sale	2020-02-06 7:22 pm	Crinetics Pharmaceuticals Inc.	CRNX	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner	13,460	$22.8	$306,888	178,816 (Indirect)	View
2020-01-29 Sale	2020-01-31 8:00 pm	Crinetics Pharmaceuticals Inc.	CRNX	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner	26,920	$22.07	$594,164	189,335 (Indirect)	View

Stock options: Exercise, Award, Grant, Conversion

Transaction Date	Reported DateTime	Exercisable Expiration	Company	Symnbol	Insider Relationship	Shares Traded	Conversion Price	Shares Owned	Filing
2021-04-27 Conversion	2021-04-29 9:10 pm	N/A N/A	IMPEL NEUROPHARMA INC	IMPL	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner	39,725,922	$0	349,674 (Indirect)	View
2021-04-27 Conversion	2021-04-29 9:10 pm	N/A N/A	IMPEL NEUROPHARMA INC	IMPL	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner	101,456	$13.5	349,674 (Indirect)	View
2021-04-22 Other	2021-04-26 6:24 pm	N/A 2021-12-31	IMPEL NEUROPHARMA INC	IMPL	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner	1,359,799	$0	1,359,799 (Indirect)	View
Ownership	2021-04-22 9:30 pm	N/A N/A	IMPEL NEUROPHARMA INC	IMPL	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner	0	$0	2,208,333 (Indirect)	View
2021-02-09 Conversion	2021-02-09 3:37 pm	N/A N/A	Bolt Biotherapeutics Inc.	BOLT	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner	3,414,343	$0	150,000 (Indirect)	View
2021-02-09 Exercise	2021-02-09 3:37 pm	N/A N/A	Bolt Biotherapeutics Inc.	BOLT	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner	64,319	$0.07	150,000 (Indirect)	View
2021-02-09 Exercise	2021-02-09 3:37 pm	N/A 2028-07-26	Bolt Biotherapeutics Inc.	BOLT	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC Vivo Opportunity Fund L.P. Vivo Opportunity LLC 10% Owner	64,319	$0	150,000 (Indirect)	View
2021-02-09 Conversion	2021-02-09 3:08 pm	N/A N/A	Terns Pharmaceuticals Inc.	TERN	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner	3,426,240	$0	357,353 (Indirect)	View
Ownership	2021-02-04 7:33 pm	N/A N/A	Bolt Biotherapeutics Inc.	BOLT	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Panda Fund L.P. Vivo Panda LLC 10% Owner	0	$0	3,521,517 (Indirect)	View
Ownership	2021-02-04 5:05 pm	N/A N/A	Terns Pharmaceuticals Inc.	TERN	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner	0	$0	2,200,133 (Indirect)	View
2020-10-20 Conversion	2020-10-20 4:59 pm	N/A N/A	Aligos Therapeutics Inc.	ALGS	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner	2,997,030	$0	430,372 (Indirect)	View
Ownership	2020-10-15 5:17 pm	N/A N/A	Aligos Therapeutics Inc.	ALGS	Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner	0	$0	2,997,030 (Indirect)	View

Insider Trading & Ownership - Vivo Capital Surplus Fund VIII L.P.